What's the Latest Eczema Research?

Today, 70% of the 18 million adults in the U.S. experience moderate-to-severe symptoms. Nearly half of people with eczema report that they "often" or "always" feel frustrated by their disease. One-third report that they spend up to three hours per day treating their disease. 

Continue reading

10 Clinical Trial Recruitment Strategies That Work

The best clinical trial recruitment strategies start by considering the patient perspective. From there, it helps to get creative. A reliable clinical trial patient recruitment plan incorporates a range of outreach methods designed to reach patients quickly and efficiently while providing them with the information they need to take the next step. 

Continue reading

Patient Centricity in Clinical Trials: Progress — and Miles to Go

A few years ago, we wrote a blog series for ACRP in which we focused on patient centricity in clinical trial design, recruitment, and execution. Over the next few months, we’ll be taking a second look at those blog posts, sharing updated versions on our own blog. Here’s an update to the first in that series. 

Continue reading

What's Next for Alzheimer's Research?

An estimated 5.8 million people in the United States have been diagnosed with Alzheimer's disease. As the millions of patients and caregivers around the country know too well, there is not a treatment option that slows or stops disease progression.

Continue reading

Crohn's Disease Research Round Up

Crohn's disease is an Inflammatory Bowel Disease (IBD) that causes chronic inflammation in the digestive tract, leading to uncomfortable abdominal pain, severe diarrhea, cramping, and other symptoms.

Continue reading

The Science of Clinical Trial Selection: Why Trial Type Matters to Patients

Living with a chronic illness or other condition can take up a significant piece of a patient's time. Though clinical trials can be beneficial to patients, recruitment efforts have to compete with many other products and services that can offer a patient support. 

Continue reading

The Quickest Way to Meet Your Clinical Trial Quotas? Precision Recruitment

With patients waiting for new and better treatments and companies waiting for results, delays in clinical trials are far from ideal. And yet, here at Antidote, we receive calls and emails every day from researchers who are missing their trial’s deadlines because they’re having trouble finding patients to take part. 

Continue reading

Autoimmune Hepatitis Diet: What Do Doctors Recommend?

While there is no recommended diet for autoimmune hepatitis, diet considerations related to weight management and alcohol consumption may both make an impact on symptoms and disease progression. Following a healthy diet and talking with your doctor about alcohol consumption can help you avoid complications related to obesity, reduce weight gain from common steroid treatments, and avoid ...

Continue reading

What Are the Stages of Idiopathic Pulmonary Fibrosis?

Idiopathic Pulmonary Fibrosis (IPF) is a rare, progressive lung disease. While there are not formal categories of IPF, doctors and patients sometimes think of IPF in four different stages depending on symptoms and treatment needs. 

Continue reading

The Best Clinical Trial Recruitment Strategies for Fast Results

As a clinical trial sponsor, you don't have time to waste. Running a clinical trial for one day can cost up to $37,000 by some estimations. Delays in new treatments hurt patients waiting for better options, too.

Continue reading